Skip to main content
SpringerLink
Log in

Calcium-Dependent Vasorelaxant Capacity of Levosimendan in Porcine and Human Epicardial Coronary Artery Preparations

  • Letter to the Editor
  • Published:
Cardiovascular Drugs and Therapy Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Köppel H, Holzmann S, Pilger E, Klein W, Gasser R. Minimal effects of levosimendan on coronary artery smooth muscle tone. Cardiovasc Drugs Ther 1999;13:357-358.

    PubMed  Google Scholar 

  2. Haikala H, Kaivola J, Nissinen E, Wall P, Levijoki J, Lindén I-B. Cardiac troponin C as a target protein for a novel calcium sensitizing drug, levosimendan. J Mol Cell Cardiol 1995;27:1859-1866.

    PubMed  Google Scholar 

  3. Sandell E-P, Häyhä M, Antila S, et al. Pharmacokinetics of levosimendan in healthy volunteers and patients with congestive heart failure. J Cardiovasc Pharmacol 1995;26:S57-S62.

    PubMed  Google Scholar 

  4. Spector W, ed. Handbook of Biological Data. Philadelphia: WB Saunders, 1956.

    Google Scholar 

  5. Pataricza J, Hohn J, Petri A, Balogh Á, Papp JGy. Comparison of the vasorelaxant effect of cromakalim and the new inodilator, levosimendan, in human isolated portal vein. J Pharm Pharmacol 2000;52:213-217.

    PubMed  Google Scholar 

  6. Rump AF, Acar D, Klaus W. A quantitative comparison of functional and anti-ischaemic effects of the phosphodiesterase-inhibitors, amrinone, milrinone and levosimendan in rabbit isolated hearts. Br J Pharmacol 1994;112:757-762.

    PubMed  Google Scholar 

  7. Haikala H, Kaheinen P, Levijoki J, Linden IB. The role of cAMP-and cGMP-dependent protein kinases in the cardiac actions of the new calcium sensitizer, levosimendan. Cardiovasc Res 1997;34:536-546.

    PubMed  Google Scholar 

  8. Lilleberg J, Nieminen MS, Akkila J, et al. Effects of anewcalcium sensitizer, levosimendan, on haemodynamics, coronary blood flow and myocardial substrate utilization early after coronary artery bypass grafting. Eur Heart J 1998;19:660-668.

    PubMed  Google Scholar 

  9. Yokoshiki H, Katsube Y, Sunagawa M, Sperelakis N. The vasodilator levosimendan hyperpolarizes and activates a glibenclamide-sensitive potassium channel in vascular smooth muscle cells. Eur J Pharmacol 1996;333:249-259.

    Google Scholar 

  10. Edwards G, Weston AH. Effect of potassium channel modulating drugs on isolated smooth muscle. In: Szekeres L, Papp JGy, eds. Handbook of Experimental Pharmacology Volume 111, Pharmacology of Smooth Muscle. Berlin Springer-Verlag, 1994:469-531.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Research Unit for Cardiovascular Pharmacology, Hungarian Academy of Sciences, Szeged, Hungary

    Irén Krassói

  2. Department of Pharmacology and Pharmacotherapy, Albert Szent-Györgyi Medical Center, University of Szeged, Hungary

    János Pataricza & Attila Kun

  3. Department of Pharmacology and Pharmacotherapy, Albert Szent-Györgyi Medical Center, University of Szeged, Hungary

    Julius Gy. Papp

Authors
  1. Irén Krassói
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. János Pataricza
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Attila Kun
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Julius Gy. Papp
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Krassói, I., Pataricza, J., Kun, A. et al. Calcium-Dependent Vasorelaxant Capacity of Levosimendan in Porcine and Human Epicardial Coronary Artery Preparations. Cardiovasc Drugs Ther 14, 691–693 (2000). https://doi.org/10.1023/A:1007883402379

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1007883402379

Search

Navigation